| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Celia F Brosnan, Cedric S Rain. The astrocyte in multiple sclerosis revisited. Glia. vol 61. issue 4. 2013-10-28. PMID:23322421. |
however, the recent upsurge of interest in the demyelinating condition neuromyelitis optica (nmo) has resulted in nmo being identified as the first disease of myelin in which primary damage to astrocytes, resulting from a humoral immune response that forms against the water channel aquaporin-4, has been documented. |
2013-10-28 |
2023-08-12 |
Not clear |
| Chen Cheng, Ying Jiang, Xiaohong Chen, Yongqiang Dai, Zhuang Kang, Zhengqi Lu, Fuhua Peng, Xueqiang H. Clinical, radiographic characteristics and immunomodulating changes in neuromyelitis optica with extensive brain lesions. BMC neurology. vol 13. 2013-10-28. PMID:23819854. |
neuromyelitis optica (nmo) shows various brain magnetic resonance imaging (mri) abnormalities with recurrent central nervous system (cns) attacks, although predominantly affecting the spinal cord and optic nerve. |
2013-10-28 |
2023-08-12 |
Not clear |
| Harleen Saini, Robert Rifkin, Michael Gorelik, Hwa Huang, Zachary Ferguson, Melina V Jones, Michael Lev. Passively transferred human NMO-IgG exacerbates demyelination in mouse experimental autoimmune encephalomyelitis. BMC neurology. vol 13. 2013-10-28. PMID:23927715. |
neuromyelitis optica (nmo) is a devastating inflammatory disorder of the optic nerves and spinal cord characterized by frequently recurring exacerbations of humoral inflammation. |
2013-10-28 |
2023-08-12 |
mouse |
| Chun-Sheng Yang, Li Yang, Ting Li, Da-Qi Zhang, Wei-Na Jin, Min-Shu Li, Ning Su, Nannan Zhangning, Qiang Liu, Zong-Hong Shao, Chunshui Yu, Fu-Dong Sh. Responsiveness to reduced dosage of rituximab in Chinese patients with neuromyelitis optica. Neurology. vol 81. issue 8. 2013-10-24. PMID:23884041. |
to determine the effect of a lower dose of rituximab in depleting b lymphocytes, maintaining low b-cell counts, and relapse in patients with neuromyelitis optica (nmo) and nmo spectrum disorders. |
2013-10-24 |
2023-08-12 |
Not clear |
| Liene Elsone, Tristan Townsend, Kerry Mutch, Kumar Das, Mike Boggild, Turo Nurmikko, Anu Jaco. Neuropathic pruritus (itch) in neuromyelitis optica. Multiple sclerosis (Houndmills, Basingstoke, England). vol 19. issue 4. 2013-10-23. PMID:22936333. |
we noted excessive pruritus in patients with neuromyelitis optica (nmo). |
2013-10-23 |
2023-08-12 |
Not clear |
| Viktoria Gredler, Simone Mader, Kathrin Schanda, Harald Hegen, Franziska Di Pauli, Bettina Kuenz, Florian Deisenhammer, Thomas Berger, Markus Reindl, Andreas Lutterott. Clinical and immunological follow-up of B-cell depleting therapy in CNS demyelinating diseases. Journal of the neurological sciences. vol 328. issue 1-2. 2013-10-23. PMID:23522498. |
the aim of this observational study was to analyze clinical and immunological effects of rituximab treatment in neuromyelitis optica (nmo) and longitudinally extensive transverse myelitis (letm) patients. |
2013-10-23 |
2023-08-12 |
Not clear |
| Sven Jarius, Brigitte Wildeman. The history of neuromyelitis optica. Journal of neuroinflammation. vol 10. 2013-10-22. PMID:23320783. |
the discovery of a novel serum autoantibody (termed nmo-igg or aqp4-ab) in a subset of patients in 2004 has revived interest in neuromyelitis optica (nmo). |
2013-10-22 |
2023-08-12 |
Not clear |
| Noriko Isobe, Tomomi Yonekawa, Takuya Matsushita, Katsuhisa Masaki, Satoshi Yoshimura, Jakub Fichna, Shu Chen, Jadwiga Furmaniak, Bernard Rees Smith, Jun-Ichi Kir. Clinical relevance of serum aquaporin-4 antibody levels in neuromyelitis optica. Neurochemical research. vol 38. issue 5. 2013-10-22. PMID:23456674. |
neuromyelitis optica (nmo) is an inflammatory disease that selectively affects the optic nerves and spinal cord. |
2013-10-22 |
2023-08-12 |
Not clear |
| Zhengjuan Lu, Dan Ye, Lai Qian, Lin Zhu, Chong Wang, Dening Guan, Xiaoguang Zhang, Yun X. Human umbilical cord mesenchymal stem cell therapy on neuromyelitis optica. Current neurovascular research. vol 9. issue 4. 2013-10-17. PMID:22873728. |
stem cell transplantation is a promising therapy for neuromyelitis optica (nmo). |
2013-10-17 |
2023-08-12 |
human |
| Xiaoli Wu, Ming Zhou, Hui Ding, Shengli Xu, Chaodong Wang, Piu Cha. Myelin oligodendrocyte glycoprotein induces aquaporin-4 autoantibodies in mouse experimental autoimmune encephalomyelitis. Journal of neuroimmunology. vol 261. issue 1-2. 2013-10-17. PMID:23707078. |
to investigate whether aqp4 autoantibodies (aqp4-ab) are causative for neuromyelitis optica (nmo), the production of aqp4-ab and clinical experimental autoimmune encephalomyelitis (eae) was investigated in mice administered with mouse aqp4 antigen or myelin oligodendrocyte glycoprotein (mog35-55) alone, and in combination. |
2013-10-17 |
2023-08-12 |
mouse |
| Wen Xu, Rui Li, Yongqiang Dai, Aimin Wu, Honghao Wang, Chen Cheng, Wei Qiu, Zhengqi Lu, Xiaonan Zhong, Yaqing Shu, Allan G Kermode, Xueqiang H. IL-22 secreting CD4+ T cells in the patients with neuromyelitis optica and multiple sclerosis. Journal of neuroimmunology. vol 261. issue 1-2. 2013-10-17. PMID:23726764. |
interleukin (il)-22 secreting cd4(+) t (th22) cells and il-22 are involved in the pathogenesis of autoimmune disease, but their role in neuromyelitis optica (nmo) and multiple sclerosis (ms) is unclear. |
2013-10-17 |
2023-08-12 |
Not clear |
| Narayanan Unni, Kavita Barhate, Nisha Ahmad, Malti Ganeshan, Bhim Singha. Neuromyelitis optica-IgG testing in an Indian cohort with neuromyelitis optica and related demyelinating disorders: Our experience. Annals of Indian Academy of Neurology. vol 16. issue 3. 2013-10-08. PMID:24101820. |
neuromyelitis optica (nmo) is an immune-mediated inflammatory demyelinating disorder of the central nervous system with a predilection for the optic nerves and the spinal cord. |
2013-10-08 |
2023-08-12 |
Not clear |
| Gokcen Gokce, Osman M Ceylan, Fatih M Mutlu, Halil I Altinsoy, Talay Koyl. Relapsing Devic's disease in a child. Journal of pediatric neurosciences. vol 8. issue 2. 2013-10-01. PMID:24082937. |
neuromyelitis optica (nmo) also named devic's disease is an acute demyelinating disorder that primarily affects the spinal cord and optic nerves. |
2013-10-01 |
2023-08-12 |
Not clear |
| Doralina Guimarães Brum, Marcelo Rizzatti Luizon, Antônio Carlos Santos, Marco Aurélio Lana-Peixoto, Cristiane Franklin Rocha, Maria Lucia Brito, Enedina Maria Lobato de Oliveira, Denis Bernardi Bichuetti, Alberto Alan Gabbai, Denise Sisterolli Diniz, Damacio Ramon Kaimen-Maciel, Elizabeth Regina Comini-Frota, Claudia E Vieira Wiezel, Yara Costa Netto Muniz, Roberta Martins da Silva Costa, Celso Teixeira Mendes-Junior, Eduardo Antônio Donadi, Amilton Antunes Barreira, Aguinaldo Luiz Simõe. European ancestry predominates in neuromyelitis optica and multiple sclerosis patients from Brazil. PloS one. vol 8. issue 3. 2013-09-27. PMID:23527051. |
neuromyelitis optica (nmo) is considered relatively more common in non-whites, whereas multiple sclerosis (ms) presents a high prevalence rate, particularly in whites from western countries populations. |
2013-09-27 |
2023-08-12 |
Not clear |
| Kai Chen Wang, Chao-Lin Lee, Shao-Yuan Chen, Jeen-Chen Chen, Chih-Wen Yang, Shyi-Jou Chen, Ching-Piao Tsa. Distinct serum cytokine profiles in neuromyelitis optica and multiple sclerosis. Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research. vol 33. issue 2. 2013-09-26. PMID:23398365. |
neuromyelitis optica (nmo) is another inflammatory demyelinating disease of the central nervous system that exhibits clinical symptoms mainly associated with optic neuritis and myelopathy. |
2013-09-26 |
2023-08-12 |
Not clear |
| Fumitaka Shimizu, Takashi Kand. [Disruption of the blood-brain barrier in inflammatory neurological diseases]. Brain and nerve = Shinkei kenkyu no shinpo. vol 65. issue 2. 2013-09-25. PMID:23399674. |
disruption of the bbb has been considered the initial key step of the disease process in some inflammatory neurological diseases, including multiple sclerosis (ms), neuromyelitis optica (nmo), and neuropsychiatric systemic lupus erythematosus (npsle). |
2013-09-25 |
2023-08-12 |
Not clear |
| Antoine Grigis, Vincent Noblet, Fréderic Blanc, Fabrice Heitz, Jérome de Seze, Stéphane Kremer, Jean-Paul Armspac. Longitudinal change detection: inference on the diffusion tensor along white matter pathways. Medical image analysis. vol 17. issue 3. 2013-09-24. PMID:23453084. |
this paper presents a change detection framework that relies on white matter pathways with application to neuromyelitis optica (nmo). |
2013-09-24 |
2023-08-12 |
Not clear |
| Ozlem Kayim Yildiz, Seyda Cevik, Ibrahim Oztopra. Consciousness disturbance and poikilothermia revealing brain involvement in neuromyelitis optica. Acta neurologica Belgica. vol 112. issue 2. 2013-09-18. PMID:22426665. |
the patient had a diagnosis of neuromyelitis optica (nmo) for 12 years and she was positive for serum anti-aquaporin 4 antibody. |
2013-09-18 |
2023-08-12 |
Not clear |
| Robert C Axtell, Chander Raman, Lawrence Steinma. Type I interferons: beneficial in Th1 and detrimental in Th17 autoimmunity. Clinical reviews in allergy & immunology. vol 44. issue 2. 2013-09-09. PMID:22231516. |
however, within the rrms population, 30-50% of ms patients are nonresponsive to this treatment, and it consistently worsens neuromyelitis optica (nmo), a disease once considered to be a form of rrms. |
2013-09-09 |
2023-08-12 |
Not clear |
| Robert C Axtell, Chander Raman, Lawrence Steinma. Type I interferons: beneficial in Th1 and detrimental in Th17 autoimmunity. Clinical reviews in allergy & immunology. vol 44. issue 2. 2013-09-09. PMID:22231516. |
these diseases include sjögren's syndrome, system lupus erythematosus (sle), neuromyelitis optica (nmo), rheumatoid arthritis (ra) and psoriasis. |
2013-09-09 |
2023-08-12 |
Not clear |